ETHYOL
Live / Registered — Registered and renewed (as of 17 Dec 2019)
What this means for you
Registered since 23 Oct 1990. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Oct 2020).
Record
- Serial number
- 73751893
- Registration number
- 1618361
- Mark type
- Word mark
- Filed
- 14 Sept 1988
- Published for opposition
- 07 Mar 1989
- Registered
- 23 Oct 1990
- Next maintenance due
- 23 Oct 2020
- Attorney of record
- Cynthia A. Moyer
Goods and services
- Class 005 — Pharmaceuticals: THERAPEUTIC DRUG ADMINISTERED IN CONNECTION WITH CHEMOTHERAPY OR RADIATION THERAPY IN THE TREATMENT OF CANCER
Owner
- CNX THERAPEUTICS LIMITED, LONDON, GB
- CLINIGEN LIMITED, STAFFORDSHIRE, GB
- CLINIGEN GROUP PLC, STAFFORDSHIRE, GB
- MEDIMMUNE, LLC, GAITHERSBURG, MD
- MEDIMMUNE ONCOLOGY, INC., WEST CONSHOHOCKEN, PA, US
- U.S. BIOSCIENCE, INC., WEST CONSHOHOCKEN, PA, US
- U.S. BIOSCIENCE, INC., BLUE BELL, PA, US
- U.S. BIOSCIENCE, INC., BLUE BELL, PA, US
Prosecution history
- 04 Oct 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Oct 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Dec 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Dec 2019 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 17 Dec 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Dec 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Nov 2019 — TEAS SECTION 8 & 9 RECEIVED
- 23 Oct 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Apr 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Nov 2010 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 22 Nov 2010 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Nov 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL